Ex-QC mayor Herbert 'Bistek' Bautista joins 2022 Senate race | ABS-CBN

ADVERTISEMENT

dpo-dps-seal
Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!

Ex-QC mayor Herbert 'Bistek' Bautista joins 2022 Senate race

Ex-QC mayor Herbert 'Bistek' Bautista joins 2022 Senate race

Katrina Domingo,

ABS-CBN News

 | 

Updated Oct 06, 2021 04:42 PM PHT

Clipboard

Former Quezon City Mayor Herbert Bautista files his certificate of candidacy for senator at the Harbour Tent at the Sofitel Hotel in Pasay City on October 06, 2021. Jonathan Cellona, ABS-CBN News
Former Quezon City Mayor Herbert Bautista files his certificate of candidacy for senator at the Harbour Tent at the Sofitel Hotel in Pasay City on October 06, 2021. Jonathan Cellona, ABS-CBN News


MANILA - Former Quezon City Mayor Herbert “Bistek” Bautista on Wednesday filed his certificate of candidacy for senator, his first bid for a national post since joining politics in the 90s.

Bautista will join the 2022 Senate slate of senators Panfilo Lacson and Vicente Sotto III.

Bautista was first known as an actor in the 80s before he shifted to politics in the 90s.

He served as councilor and vice mayor of Quezon City before ascending to the city’s mayoralty post from 2010 to 2019.

ADVERTISEMENT

In 2012, the Manila Seedling Bank Foundation Inc. (MSBFI) filed graft charges against Bautista and 6 others over the alleged illegal takeover of the local government of a 7-hectare land in North Triangle.

The Quezon City government took over the land located on the corner of Quezon Avenue and EDSA after MSBFI allegedly failed to pay taxes worth around P59 million, but the foundation’s management claimed that they are exempt from paying taxes.

Last year, the former Quezon City mayor faced 3 other graft charges over the local government’s purchase of allegedly defective solar panels and CCTV cameras.

FROM THE ARCHIVES

Watch more in iWantv or TFC.tv

ADVERTISEMENT

ADVERTISEMENT

It looks like you’re using an ad blocker

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.